Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Joseph

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profilesAndreia P Soares, Thomas J Scriba, Sarah Joseph, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levelsMark Booth, Marie A Shaw, Danielle Carpenter, et al.
The Journal of Infectious Diseases|July 10, 2004
Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfectionSarah Joseph, Frances M Jones, Maureen E Laidlaw, et al.
Clinical and Vaccine Immunology : CVI|May 10, 2006
Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantelClaus M Reimert, Colin M Fitzsimmons, Sarah Joseph, et al.
Scientific Reports|September 22, 2017
A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan AfricaVicky Jespers, Jordan Kyongo, Sarah Joseph, et al.
Frontiers in Immunology|July 21, 2025
Vaginal microbiome dysbiosis and sexually transmitted infections correlate with concentrations of immunoglobulin isotypes in human cervicovaginal mucus: insights into HIV-1 transmissionMatrona M Akiso, Israel Abook, Marianne W Mureithi, et al.
Journal of Public Health Management and Practice : JPHMP|November 19, 2021
Community-Informed Mobile COVID-19 Testing Model to Addressing Health InequitiesJonathan Jiménez, Yury J Parra, Katherine Murphy, et al.
Protein Science : a Publication of the Protein Society|February 4, 2015
AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activityKrishnamurthy Narasimha Rao, Anirudha Lakshminarasimhan, Sarah Joseph, et al.
Plos One|November 5, 2025
Endocervix exhibits greater susceptibility to HIV-1 infection compared to ectocervix following ex vivo exposure to Transmitted/Founder HIV-1 variantsRobert Langat, Michael D McRaven, Ramon Lorenzo-Redondo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigensKlaudia Walter, Anthony J C Fulford, Rowena McBeath, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Bacillus Calmette-Guérin vaccination of human newborns induces T cells with complex cytokine and phenotypic profilesAndreia P Soares, Thomas J Scriba, Sarah Joseph, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2006
Carriage of DRB1*13 is associated with increased posttreatment IgE levels against Schistosoma mansoni antigens and lower long-term reinfection levelsMark Booth, Marie A Shaw, Danielle Carpenter, et al.
The Journal of Infectious Diseases|July 10, 2004
Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfectionSarah Joseph, Frances M Jones, Maureen E Laidlaw, et al.
Clinical and Vaccine Immunology : CVI|May 10, 2006
Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantelClaus M Reimert, Colin M Fitzsimmons, Sarah Joseph, et al.
Scientific Reports|September 22, 2017
A longitudinal analysis of the vaginal microbiota and vaginal immune mediators in women from sub-Saharan AfricaVicky Jespers, Jordan Kyongo, Sarah Joseph, et al.
Frontiers in Immunology|July 21, 2025
Vaginal microbiome dysbiosis and sexually transmitted infections correlate with concentrations of immunoglobulin isotypes in human cervicovaginal mucus: insights into HIV-1 transmissionMatrona M Akiso, Israel Abook, Marianne W Mureithi, et al.
Journal of Public Health Management and Practice : JPHMP|November 19, 2021
Community-Informed Mobile COVID-19 Testing Model to Addressing Health InequitiesJonathan Jiménez, Yury J Parra, Katherine Murphy, et al.
Protein Science : a Publication of the Protein Society|February 4, 2015
AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activityKrishnamurthy Narasimha Rao, Anirudha Lakshminarasimhan, Sarah Joseph, et al.
Plos One|November 5, 2025
Endocervix exhibits greater susceptibility to HIV-1 infection compared to ectocervix following ex vivo exposure to Transmitted/Founder HIV-1 variantsRobert Langat, Michael D McRaven, Ramon Lorenzo-Redondo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigensKlaudia Walter, Anthony J C Fulford, Rowena McBeath, et al.
Pageof 8